Search Results - "Maas, C C H M"

Performance metrics for models designed to predict treatment effect by Maas, C C H M, Kent, D M, Hughes, M C, Dekker, R, Lingsma, H F, van Klaveren, D

“…Measuring the performance of models that predict individualized treatment effect is challenging because the outcomes of two alternative treatments are…”
Get full text

Pitfalls of single-study external validation illustrated with a model predicting functional outcome after aneurysmal subarachnoid hemorrhage by de Winkel, Jordi, Maas, Carolien C H M, Roozenbeek, Bob, van Klaveren, David, Lingsma, Hester F

“…Prediction models are often externally validated with data from a single study or cohort. However, the interpretation of performance estimates obtained with…”
Get full text

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma by Maas, Carolien C. H. M., van Klaveren, David, Durmaz, Müjde, Visser, Otto, Issa, Djamila E., Posthuma, Eduardus F. M., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.

“…First-line treatment for advanced-stage diffuse large B-cell lymphoma (DLBCL) typically involves 6x R-CHOP21 or 6x R-CHOP21 with two additional rituximab…”
Get full text

Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018 by van der Straten, Lina, Maas, Carolien C. H. M., Levin, Mark-David, Visser, Otto, Posthuma, Eduardus F. M., Doorduijn, Jeanette K., Langerak, Anton W., Kater, Arnon P., Dinmohamed, Avinash G.

Get full text

Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effects by van Klaveren, David, Maas, Carolien C H M, Kent, David M

Get full text

Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis by Stassen, Robert C, Maas, Carolien C H M, van der Veldt, Astrid A M, Lo, Serigne N, Saw, Robyn P M, Varey, Alexander H R, Scolyer, Richard A, Long, Georgina V, Thompson, John F, Rutkowski, Piotr, Keilholz, Ulrich, van Akkooi, Alexander C J, Verhoef, Cornelis, van Klaveren, David, Grünhagen, Dirk J

“…The introduction of adjuvant systemic treatment for patients with high-risk melanomas necessitates accurate staging of disease. However, inconsistencies in…”
Get full text

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018 by Maas, Carolien C. H. M., Klaveren, David, Ector, Geneviève I. C. G., Posthuma, Eduardus F. M., Visser, Otto, Westerweel, Peter E., Janssen, Jeroen J. W. M., Blijlevens, Nicole M. A., Dinmohamed, Avinash G.

“…Summary Studies on the conditional life expectancy of patients with chronic myeloid leukaemia (CML) are lacking. Using data from the Netherlands Cancer…”
Get full text

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era by Dinnessen, Manette A. W., Maas, Carolien C. H. M., Tonino, Sanne H., Visser, Otto, Posthuma, Eduardus F. M., Blijlevens, Nicole M. A., Kersten, Marie José, Lugtenburg, Pieternella J., Dinmohamed, Avinash G.

Get full text

Disability weights for environmental noise-related health states: results of a disability weights measurement study in Europe by Juanita A Haagsma, Periklis Charalampous, Carolien C H M Maas

“…Introduction Measurement of the burden of disease using disability-adjusted life years requires disability weights to quantify health losses for non-fatal…”
Get full text

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome by van Tilburg, Sander J., Teunissen, Charlotte E., Maas, Carolien C.H.M., Thomma, Robin C.M., Walgaard, Christa, Heijst, Hans, Huizinga, Ruth, van Doorn, Pieter A., Jacobs, Bart C.

“…Neurofilament light chain (NfL) is a biomarker for axonal damage in several neurological disorders. We studied the longitudinal changes in serum NfL in…”
Get full text

Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989–2019 by Maas, Carolien C.H.M., van Klaveren, David, Visser, Otto, Merkx, Matthias A.W., Lingsma, Hester F., Lemmens, Valery E.P.P., Dinmohamed, Avinash G.

“…Loss of life expectancy (LOLE) may provide more intuitive information on the impact of cancer than relative survival over a fixed time horizon (e.g., 5-year…”
Get full text

Growth hormone responses during strenuous exercise : the role of GH-releasing hormone and GH-releasing peptide-2 by MAAS, H. C. M, DE VRIES, W. R, MAITIMU, I, BOL, E, BOWERS, C. Y, KOPPESCHAAR, H. P. F

“…This study was designed to investigate the role of two effective releasers of growth hormone (GH): GHRH and GHRP-2 during exercise (EX). Eight healthy male…”
Get full text

Pre-operative dynamic interactive exploration of complex articular fractures using a novel 3D navigation tool by Marschollek, M, Teistler, M, Bott, O J, Stuermer, K M, Pretschner, D P, Dresing, K

“…Trauma surgeons possess specific anticipative pathoanatomical and procedural domain knowledge that can be used for information extraction from original CT…”
Get more information

Establishing an international reference image database for research and development in medical image processing by Horsch, A, Prinz, M, Schneider, S, Sipilä, O, Spinnler, K, Vallée, J-P, Verdonck-de Leeuw, I, Vogl, R, Wittenberg, T, Zahlmann, G

“…The lack of comparability of evaluation results is one of the major obstacles of research and development in Medical Image Processing (MIP). The main reason…”
Get more information